BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21395681)

  • 1. Comparison of the approaches to non-febrile neutropenia developing in children with acute lymphoblastic leukemia.
    Paksu MS; Paksu S; Akbalik M; Ozyurek E; Duru F; Albayrak D; Fisgin T
    Fundam Clin Pharmacol; 2012 Jun; 26(3):418-23. PubMed ID: 21395681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia.
    Pui CH; Boyett JM; Hughes WT; Rivera GK; Hancock ML; Sandlund JT; Synold T; Relling MV; Ribeiro RC; Crist WM; Evans WE
    N Engl J Med; 1997 Jun; 336(25):1781-7. PubMed ID: 9187068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study.
    Heath JA; Steinherz PG; Altman A; Sather H; Jhanwar S; Halpern S; Pieters R; Shah N; Steinherz L; Tannous R; Terry W; Trigg ME;
    J Clin Oncol; 2003 Apr; 21(8):1612-7. PubMed ID: 12697887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group.
    Ozkaynak MF; Krailo M; Chen Z; Feusner J
    Pediatr Blood Cancer; 2005 Sep; 45(3):274-80. PubMed ID: 15806544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of G-CSF and high-dose methylprednisolone on peripheral stem cells, serum IL-3 levels and hematological parameters in acute lymphoblastic leukemia patients with neutropenia: a pilot study.
    Ozbek N; Yetgin S; Tuncer AM
    Leuk Res; 2000 Jan; 24(1):55-8. PubMed ID: 10634646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloprotective effect of short-course high-dose methylprednisolone treatment before consolidation therapy in children with acute myeloblastic leukemia.
    Elmas SA; Cetin M; Tuncer M; Hiçsönmez G
    Am J Hematol; 2005 Sep; 80(1):1-5. PubMed ID: 16138333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum TNF-alpha, gamma-INF, G-CSF and GM-CSF levels in neutropenic children with acute leukemia treated with short-course, high-dose methylprednisolone.
    Tuncer AM; Hiçsönmez G; Gümrük F; Sayli T; Güler E; Cetin M; Okur H
    Leuk Res; 1996 Mar; 20(3):265-9. PubMed ID: 8637222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of short-course high-dose corticosteroid therapy on peripheral blood CD34+ progenitor cells in children with acute leukemia.
    Cetin M; Hiçsönmez G; Tuncer AM; Kansu E; Canpynar H
    Exp Hematol; 1996 Aug; 24(10):1191-4. PubMed ID: 8765493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled study of granulocyte colony stimulating factor after intensive induction and consolidation therapy in patients with acute lymphoblastic leukemia. Japan Adult Leukemia Study Group.
    Ohno R; Tomonaga M; Ohshima T; Masaoka T; Asou N; Oh H; Nishikawa K; Kanamaru A; Murakami H; Furusawa S
    Int J Hematol; 1993 Aug; 58(1-2):73-81. PubMed ID: 7693029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
    Ghalaut PS; Sen R; Dixit G
    J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutropenic complications in advanced-stage non-Hodgkin's lymphoma: implications for the use of prophylactic recombinant human granulocyte-colony stimulating factor (G-CSF).
    Bobey N; Woodman RC
    Clin Invest Med; 1998 Apr; 21(2):63-70. PubMed ID: 9562926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer.
    Crawford J; Ozer H; Stoller R; Johnson D; Lyman G; Tabbara I; Kris M; Grous J; Picozzi V; Rausch G
    N Engl J Med; 1991 Jul; 325(3):164-70. PubMed ID: 1711156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefit of high-dose methylprednisolone in comparison with conventional-dose prednisolone during remission induction therapy in childhood acute lymphoblastic leukemia for long-term follow-up.
    Yetgin S; Tuncer MA; Cetin M; Gümrük F; Yenicesu I; Tunç B; Oner AF; Toksoy H; Koç A; Aslan D; Ozyürek E; Olcay L; Atahan L; Tunçbilek E; Gürgey A
    Leukemia; 2003 Feb; 17(2):328-33. PubMed ID: 12592331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil recovery time and adverse side effects in acute leukemia patients treated with intensive chemotherapy and concomitant G or GM-CSF.
    Alvarado Ibarra ML; Borbolla Escoboza JR; López-Hernández MA; González-Avante CM; FloresChapa JD; Trueba Christy E; Anaya Cuellar I
    Rev Invest Clin; 1999; 51(2):77-80. PubMed ID: 10410585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent granulocyte colony-stimulating factor maintains dose intensity after ABVD therapy complicated by neutropenia.
    Ho P; Sherman P; Grigg A
    Eur J Haematol; 2012 May; 88(5):416-21. PubMed ID: 22296221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual timing of blood counts in G-CSF prophylaxis after myelosuppressive chemotherapy reduces G-CSF injections, blood counts, and costs: a prospective randomized study in children and adolescents.
    Ammann RA; Leibundgut K; Hirt A; Ridolfi Lüthy A
    Support Care Cancer; 2002 Nov; 10(8):613-8. PubMed ID: 12436219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective randomized trial to evaluate two delayed granulocyte colony stimulating factor administration schedules after high-dose cytarabine therapy in adult patients with acute lymphoblastic leukemia.
    Hofmann WK; Seipelt G; Langenhan S; Reutzel R; Schott D; Schoeffski O; Illiger HJ; Hartmann F; Balleisen L; Franke A; Fiedler F; Huber C; Rasche H; Bergmann L; Ganser A; Pott C; Pasold R; Rudolph C; Ottmann OG; Gökbuget N; Hoelzer D
    Ann Hematol; 2002 Oct; 81(10):570-4. PubMed ID: 12424538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprophylaxis with oral ciprofloxacin in ovarian cancer patients receiving taxol.
    Carlson JW; Fowler JM; Saltzman AK; Carter JR; Chen MD; Mitchell SK; Dunn D; Carson LF; Adcock LL; Twiggs LB
    Gynecol Oncol; 1994 Dec; 55(3 Pt 1):415-20. PubMed ID: 7530677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.